Patent · US Active

Method and device for blood glucose level monitoring

US11363974B2 · kind B2 · utility

0Cited by

2References

18Claims

0Family size

Assignee

SONY GROUP CORPORATION · JP

Inventors

Jim Rasmusson · Lund, SE
Peter Karlsson · Lund, SE
Magnus Svensson · Gothenburg, SE
Claes Nilsson · Lund, SE
Jimmy Eklund · Lund, SE

Key dates

Filing date	May 30, 2019
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Feb 5, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61B5/7282
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method for monitoring a blood glucose level of an individual comprises the steps of receiving (S1) a first glucose value, which has been measured in a body fluid of the individual other than the individual's blood, the first glucose value representing the blood glucose level of the individual with a first delay; receiving (S6) speech of the individual; analyzing (S7) the individual's speech; and determining (S8) a supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the supplementary glucose value is based on the analyzing of the individual's speech.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.